Interim safety of pertuzumab in combination with trastuzumab and vinorelbine for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer

被引：0
|
作者：
Perez, E. [1 ]
Lopez-Vega, J. M. [2 ]
Petit, T. [3 ,4 ]
Zamagni, C. [5 ]
Freudensprung, U. [6 ]
Bastiere-Truchot, L. [7 ]
Walker, R. [7 ]
Andersson, M. [8 ]
机构：
[1] Mayo Clin, Div Hematol Oncol, Jacksonville, FL USA
[2] Hosp Univ Marques de Valdecilla, Dept Med Oncol, Santander, Spain
[3] Paul Strauss Canc Ctr, Strasbourg, France
[4] Univ Strasbourg, Dept Med Oncol, Strasbourg, France
[5] Policlin S Orsola Malpighi Hosp, Med Oncol Unit, Bologna, Italy
[6] Stamford Consultants AG, Basel, Switzerland
[7] Roche, Basel, Switzerland
[8] Rigshosp, Dept Oncol, Copenhagen, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S178 / S179
页数：2
相关论文
共 50 条
  • [1] Safety of pertuzumab plus trastuzumab plus vinorelbine for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer
    Perez, E. A.
    Lopez-Vega, J. M.
    Del Mastro, L.
    Petit, T.
    Zamagni, C.
    Freudensprung, U.
    Bastiere-Truchot, L.
    Walker, R.
    Andersson, M.
    [J]. CANCER RESEARCH, 2013, 73
  • [2] Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results
    Perez, Edith A.
    Manuel Lopez-Vega, Jose
    Petit, Thierry
    Zamagni, Claudio
    Easton, Valerie
    Kamber, Julia
    Restuccia, Eleonora
    Andersson, Michael
    [J]. BREAST CANCER RESEARCH, 2016, 18
  • [3] Safety and efficacy of vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with HER2-positive locally advanced or metastatic breast cancer: VELVET Cohort 1 final results
    Edith A. Perez
    José Manuel López-Vega
    Thierry Petit
    Claudio Zamagni
    Valerie Easton
    Julia Kamber
    Eleonora Restuccia
    Michael Andersson
    [J]. Breast Cancer Research, 18
  • [4] Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer
    Farhat, Fadi
    Kattan, Joseph G.
    Ghosn, Marwan
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (05) : 1069 - 1077
  • [5] Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer
    Fadi Farhat
    Joseph G. Kattan
    Marwan Ghosn
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 77 : 1069 - 1077
  • [6] Oral vinorelbine in combination with trastuzumab as a first line therapy of metastatic or locally advanced HER2-positive breast cancer
    Ghosn, M.
    Kattan, J.
    Chahine, G.
    Makdessi, J.
    Bitar, N.
    El-Mouhebb, M.
    Mourad, C.
    Farhat, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S182 - S183
  • [7] ORAL VINORELBINE IN COMBINATION WITH TRASTUZUMAB AS A FIRST LINE THERAPY OF METASTATIC OR LOCALLY ADVANCED HER2-POSITIVE BREAST CANCER
    Farhat, Fadi
    Kattan, Joseph
    Ghosn, Marwan
    [J]. BREAST, 2015, 24 : S42 - S43
  • [8] Oral vinorelbine in combination with trastuzumab as a first line therapy of metastatic or locally advanced Her2-positive breast cancer
    Farhat, F.
    Kattan, J.
    Chahine, G.
    Makdessi, J.
    Bitar, N.
    Ghosn, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S281 - S281
  • [9] Pertuzumab In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
    Keating, Gillian M.
    [J]. DRUGS, 2012, 72 (03) : 353 - 360
  • [10] Taxane versus vinorelbine in combination with pertuzumab and trastuzumab for first-line treatment of patients with metastatic HER2-positive breast cancer - A retrospective two-center study
    Reinhorn, Daniel Jack
    Kuchuk, Irina
    Prus, Judit
    Sarfaty, Michal
    Goldvaser, Hadar
    Rotem, Ofer
    Hendler, Daniel
    Zoref, Dalia
    Neiman, Victoria
    Shohat, Tzipora
    Ulitsky, Olga
    Yust-Katz, Shlomit
    Nisenbaum, Bella
    Gottfried, Maya
    Yerushalmi, Rinat
    [J]. CANCER RESEARCH, 2020, 80 (04)
12345